Search results
Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH
… to Non-Alcoholic Steatohepatitis (NASH) This study is to evaluate the safety and efficacy of simtuzumab …
Last Modified:
healthpoints Spring 2016
… patients with end-stage kidney disease, dialysis lifeline is critical Peripheral Arterial Disease : What you must know …
Last Modified:
Post-Approval Study Of Transcarotid Artery Revascularization In Patients With Significant Carotid Artery Disease
… Study Overview The ROADSTER 2 Study is an open label, single arm, multi-center post-approval …
Last Modified:
Weight Loss Surgery Newsletter June 2018
… AND Marriages after Bariatric Surgery Weight-Loss Surgery is Cost Effective Sign Up for Email Newsletters » …
Last Modified:
Columbia Scores Top in the Nation for Complex Procedures for Heart, Lung, and Colorectal Care
… as a top 10 national hospital for more than 10 years. What is the US News & World Report? The US News & World Report … More on Surgical Rankings & Columbia Columbia is Top Choice for Valve Replacement & CABG Surgery Pediatric …
Last Modified:
Jean C. Emond, MD
… Dr. Emond is the Vice Chairman of Surgery at Columbia University. He … and international leadership in transplantation, Dr. Emond is the past president of the American Society of Transplant …
Last Modified:
Support & Educational Resources for Patients
… process. Before Surgery Each patient and caregiver is required to meet with a social worker and psychiatrist … face a whole new set of challenges and goals. This is why we strongly encourage all transplant recipients and … Side Effects – Dr. David Salerno More Liver Connection is a quarterly newsletter that contains articles on all …
Last Modified:
Organ Transplant at Columbia
… the top in the field. Within all our transplant programs is a culture dedicated to research and innovation that’s … Program Our kidney and pancreas transplant program is one of the longest running and busiest programs in the … for both children and adults. If transplant surgery is needed, patients have access to the largest living donor …
Last Modified:
Xiaowei Chen, MD
… Dr. Xiaowei Chen is a board certified pathologist who specializes in …
Last Modified:
Prospective Randomized Double Blind Placebo Controlled Trial of Rifaximin 550mg PO Twice Daily for Three Months to Prevent Recurrent Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C Virus Infection
… The purpose of this study is to determine if the administration of a poorly-absorbable …
Last Modified:
General Surgery Presentations and Research
… This quarterly report is a summary of the monthly Faculty Research Newsletter. …
Last Modified:
Simtuzumab (GS-6624) in Treatment of Advanced Liver Fibrosis But Not Cirrhosis Secondary to NASH
… whether simtuzumab (formerly referred to as GS-6624) is effective at preventing the histologic progression of …
Last Modified:
A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination with Sofosbuvir for the Treatment of Post-Liver Transplant Subjects with Chronic Hepatitis C
… The primary objective of this program is to provide DCV for 24 weeks to be given in combination …
Last Modified: